Ask the expert: Triple-negative breast cancer
Making up 15 to 20 percent of all breast cancer diagnoses, triple-negative breast cancer (TNBC) is often seen as a more aggressive subtype that disproportionally affects young, Black, and Latinx communities.
Oncologist Elaine Walsh, MB BCh BAO, PhD answers questions about TNBC symptoms, side-effects, and treatment options for early stage and metastatic breast cancer.
Understanding your sub-type and its treatment options will help you make the best decisions for you.
About our expert
Elaine Walsh, MB BCh BAO, PhD, is a medical oncologist who specializes in the treatment of people with breast cancer. At Memorial Sloan Kettering Cancer Center, Dr. Walsh works as part of a multidisciplinary team to provide the highest level of care and best treatment options to people with breast cancer, while taking individual preferences and priorities into account. Read more.